Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
OtherClinical Investigations (Human)

Multi-phasic 68Ga-PSMA PET/CT in detection of early recurrence in prostate cancer patients with PSA < 1 ng/ml: a prospective study of 135 cases.

Mohsen Beheshti, Reyhaneh Manafi-Farid, Hans Geinitz, Reza Vali, Wolfgang Loidl, Felix M. Mottaghy and Werner Langsteger
Journal of Nuclear Medicine February 2020, jnumed.119.238071; DOI: https://doi.org/10.2967/jnumed.119.238071
Mohsen Beheshti
1 Department of Nuclear Medicine, University Hospital, RWTH University, Aachen, Germany, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Reyhaneh Manafi-Farid
2 Research Center for Nuclear Medicine, Shariati Hospital, Tehran University of Medical Sciences, Iran, Islamic Republic of;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hans Geinitz
3 Department of Radiation Oncology, Ordensklinikum, St. Vincent's Hospital, Austria;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Reza Vali
4 Department of Diagnostic Imaging, The Hospital for Sick Children, University of Toronto,, Canada;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wolfgang Loidl
5 Department of Urology, Prostate Cancer Center, Ordensklinikum, Austria;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Felix M. Mottaghy
1 Department of Nuclear Medicine, University Hospital, RWTH University, Aachen, Germany, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Werner Langsteger
6 Dept of Nuclear Medicine & Endocrinology, PET - CTCenter LINZ, Ordensklinikum, St Vincent's Hospital
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Article Information

jnumed.119.238071
DOI 
https://doi.org/10.2967/jnumed.119.238071
PubMed 
32060214

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online February 14, 2020.

Article Versions

  • You are currently viewing a previous version of this article (February 14, 2020 - 14:01).
  • View the most recent version of this article
Copyright & Usage 
Copyright © 2020 by the Society of Nuclear Medicine and Molecular Imaging, Inc.

Author Information

  1. Mohsen Beheshti1,
  2. Reyhaneh Manafi-Farid2,
  3. Hans Geinitz3,
  4. Reza Vali4,
  5. Wolfgang Loidl5,
  6. Felix M. Mottaghy1 and
  7. Werner Langsteger6
  1. 1 Department of Nuclear Medicine, University Hospital, RWTH University, Aachen, Germany, Germany;
  2. 2 Research Center for Nuclear Medicine, Shariati Hospital, Tehran University of Medical Sciences, Iran, Islamic Republic of;
  3. 3 Department of Radiation Oncology, Ordensklinikum, St. Vincent's Hospital, Austria;
  4. 4 Department of Diagnostic Imaging, The Hospital for Sick Children, University of Toronto,, Canada;
  5. 5 Department of Urology, Prostate Cancer Center, Ordensklinikum, Austria;
  6. 6 Dept of Nuclear Medicine & Endocrinology, PET - CTCenter LINZ, Ordensklinikum, St Vincent's Hospital
  1. For correspondence or reprints contact: Mohsen Beheshti, Department of Nuclear Medicine, University Hospital, RWTH University, Aachen, Germany, Pauwelsstrasse 30, Aachen 52074, Germany. E-mail: mbeheshti@ukaachen.de

Statistics from Altmetric.com

Cited By...

  • 35 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Prostate-specific Membrane Antigen PET in Prostate Cancer
    Courtney Lawhn-Heath, Ali Salavati, Spencer C. Behr, Steven P. Rowe, Jeremie Calais, Wolfgang P. Fendler, Mattias Eiber, Louise Emmett, Michael S. Hofman, Thomas A. Hope
    Radiology 2021 299 2
  • Non-invasive molecular imaging of kidney diseases
    Barbara M. Klinkhammer, Twan Lammers, Felix M. Mottaghy, Fabian Kiessling, Jürgen Floege, Peter Boor
    Nature Reviews Nephrology 2021 17 10
  • Factors predicting biochemical response and survival benefits following radioligand therapy with [177Lu]Lu-PSMA in metastatic castrate-resistant prostate cancer: a review
    Reyhaneh Manafi-Farid, Sara Harsini, Bahare Saidi, Hojat Ahmadzadehfar, Ken Herrmann, Alberto Briganti, Jochen Walz, Mohsen Beheshti
    European Journal of Nuclear Medicine and Molecular Imaging 2021 48 12
  • PSMA PET imaging in the diagnosis and management of prostate cancer
    Sina Houshmand, Courtney Lawhn-Heath, Spencer Behr
    Abdominal Radiology 2023 48 12
  • Comparing the diagnostic performance of radiotracers in prostate cancer biochemical recurrence: a systematic review and meta-analysis
    Weili Ma, Jiwei Mao, Jianfeng Yang, Ting Wang, Zhen Hua Zhao
    European Radiology 2022 32 11
  • Detection Efficacy of 68Ga-PSMA-11 PET/CT in Biochemical Recurrence of Prostate Cancer with Very Low PSA Levels: A 7-Year, Two-Center “Real-World” Experience
    Caroline Burgard, Manuela A. Hoffmann, Madita Frei, Hans-Georg Buchholz, Fadi Khreish, Robert J. Marlowe, Mathias Schreckenberger, Samer Ezziddin, Florian Rosar
    Cancers 2023 15 5
  • Molecular Imaging in Primary Staging of Prostate Cancer Patients: Current Aspects and Future Trends
    Reyhaneh Manafi-Farid, Shaghayegh Ranjbar, Zahra Jamshidi Araghi, Julia Pilz, Gregor Schweighofer-Zwink, Christian Pirich, Mohsen Beheshti
    Cancers 2021 13 21
  • [89Zr]Zr-PSMA-617 PET/CT in biochemical recurrence of prostate cancer: first clinical experience from a pilot study including biodistribution and dose estimates
    Florian Rosar, Andrea Schaefer-Schuler, Mark Bartholomä, Stephan Maus, Sven Petto, Caroline Burgard, Bastiaan M. Privé, Gerben M. Franssen, Yvonne H. W. Derks, James Nagarajah, Fadi Khreish, Samer Ezziddin
    European Journal of Nuclear Medicine and Molecular Imaging 2022 49 13
  • Survey by the French Medicine Agency (ANSM) of the imaging protocol, detection rate, and safety of 68Ga-PSMA-11 PET/CT in the biochemical recurrence of prostate cancer in case of negative or equivocal 18F-fluorocholine PET/CT: 1084 examinations
    Yanna-Marina Chevalme, Lotfi Boudali, Mathieu Gauthé, Caroline Rousseau, Andrea Skanjeti, Charles Merlin, Philippe Robin, Anne-Laure Giraudet, Marc Janier, Jean-Noël Talbot
    European Journal of Nuclear Medicine and Molecular Imaging 2021 48 9
  • Pattern of Prostate Cancer Recurrence Assessed by 68Ga-PSMA-11 PET/CT in Men Treated with Primary Local Therapy
    Ismaheel O. Lawal, Thabo Lengana, Gbenga O. Popoola, Akintunde T. Orunmuyi, Mankgopo M. Kgatle, Kgomotso M. G. Mokoala, Mike M. Sathekge
    Journal of Clinical Medicine 2021 10 17

Article usage

Article usage: February 2020 to April 2025

AbstractFullPdf
Feb 2020490063
Mar 2020262030
Apr 2020132014
May 202073011
Jun 20207508
Jul 20204802
Aug 202083031
Sep 202074015
Oct 2020134022127
Nov 20202561028
Dec 20201411122
Jan 20211231625
Feb 2021103918
Mar 20211472020
Apr 2021418452
May 2021245230
Jun 2021284942
Jul 2021176661
Aug 2021145326
Sep 2021174825
Oct 2021134554
Nov 2021215649
Dec 2021205329
Jan 2022203325
Feb 2022192110
Mar 202293028
Apr 2022155640
May 2022123232
Jun 2022122013
Jul 2022185623
Aug 2022123921
Sep 2022124822
Oct 202215359
Nov 2022126227
Dec 2022203713
Jan 202395225
Feb 2023125422
Mar 2023810515
Apr 202392612
May 2023133822
Jun 202334420
Jul 202394117
Aug 2023144519
Sep 202375321
Oct 2023215131
Nov 202366512
Dec 20238399
Jan 202484821
Feb 2024144419
Mar 202463039
Apr 2024107623
May 202475420
Jun 202435712
Jul 2024144829
Aug 202483025
Sep 202445718
Oct 2024113923
Nov 202455317
Dec 202465131
Jan 202583613
Feb 2025107417
Mar 2025128340
Apr 202577868
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 66 (5)
Journal of Nuclear Medicine
Vol. 66, Issue 5
May 1, 2025
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Complete Issue (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Multi-phasic 68Ga-PSMA PET/CT in detection of early recurrence in prostate cancer patients with PSA < 1 ng/ml: a prospective study of 135 cases.
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Multi-phasic 68Ga-PSMA PET/CT in detection of early recurrence in prostate cancer patients with PSA < 1 ng/ml: a prospective study of 135 cases.
Mohsen Beheshti, Reyhaneh Manafi-Farid, Hans Geinitz, Reza Vali, Wolfgang Loidl, Felix M. Mottaghy, Werner Langsteger
Journal of Nuclear Medicine Feb 2020, jnumed.119.238071; DOI: 10.2967/jnumed.119.238071

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Multi-phasic 68Ga-PSMA PET/CT in detection of early recurrence in prostate cancer patients with PSA < 1 ng/ml: a prospective study of 135 cases.
Mohsen Beheshti, Reyhaneh Manafi-Farid, Hans Geinitz, Reza Vali, Wolfgang Loidl, Felix M. Mottaghy, Werner Langsteger
Journal of Nuclear Medicine Feb 2020, jnumed.119.238071; DOI: 10.2967/jnumed.119.238071
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • Association of Free-to-Total PSA Ratio and 18F-DCFPyL Prostate-Specific Membrane Antigen PET/CT Findings in Patients with Biochemical Recurrence After Radical Prostatectomy: A Prospective Single-Center Study
  • Tumor Sink Effect: Myth or Reality?
  • Google Scholar

More in this TOC Section

Clinical Investigations (Human)

  • The added value of 18F-FDG PET/CT compared to 68Ga-PSMA PET/CT in patients with castration-resistant prostate cancer
Show more Clinical Investigations (Human)

Clinical (Oncology: GU)

  • Pretherapeutic Comparative Dosimetry of 177Lu-rhPSMA-7.3 and 177Lu-PSMA I&T in Patients with Metastatic Castration-Resistant Prostate Cancer
  • A Comparison of 18F-DCFPyL, 18F-NaF, and 18F-FDG PET/CT in a Prospective Cohort of Men with Metastatic Prostate Cancer
  • Detection of Additional Primary Neoplasms on 18F-Fluciclovine PET/CT in Patients with Primary Prostate Cancer
Show more Clinical (Oncology: GU)

Similar Articles

Keywords

  • Oncology: GU
  • PET/CT
  • 68Ga-PSMA PET/CT
  • low PSA
  • prostate cancer recurrence
  • multi-phasic imaging
SNMMI

© 2025 SNMMI

Powered by HighWire